跳至主要内容
临床试验/CTRI/2020/03/023837
CTRI/2020/03/023837已完成1/2 期

Randomized comparative cinical trial to study the effficacy of Katphaladi Churna and Tablet Levocetrizine[5mg] with Montelukast [10mg] in Peenasa Vyadhi.

Sane Guruji Arogya Kendra1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2020年1月4日最近更新:

试验速览

阶段
1/2 期
状态
已完成
入组人数
72
试验地点
1
主要终点
A clinical study to evaluate efficacy

研究概览

简要总结

This study is open labelled randomized controlled clinical trial to evaluate the effect of Katphaladi Churna daily for 15 days in comparison with Tab Levocetrizine 5mg in combination with Montelukast 10mg of patients affected with Peenasa Vyadhi w.r.t Chronic Simple Rhinitis. The Primary outcome will be effect of Katphaladi Churna and the secondary outcome will be comparison between trial drug and control drug in management of Peenasa Vyadhi w.r.t Chronic Simple Rhinitis.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Open Label

入排标准

年龄范围
20.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Patients from age group of 20 to 50 years.
  • Patients irrespective of gender and religion.
  • Patients having signs and signs and symptoms of Peenasaa Vyadhi(Chronic SimpleRhinitis) like Nasal Obstruction, Post-Nasal Drip, Partial loss of Smell(Anosmia).

排除标准

  • Patients suffering from known case of chronic specific infective rhinitis like Syphilis, leprosy, T.B. lupus Vulgaris, Rhinosporidiosis, Rhinoscleroma, fungal Infections, leishmaniasis.
  • Patients with systemic diseases and known case of Hypertension, Respiratory disorder, Diabetes Mellitus, HBsAg, HIV.
  • Patients with DNS, Nasal polyp, Asthma, Tumors or any nasal pathology.
  • Patient not willing for treatment and irregular follow up.

结局指标

主要结局

A clinical study to evaluate efficacy

时间窗: The drug will be given 15 days. The patients will | be assessed before and after treatment. Total | duration of the study will 18 months.

of Katphaladi Churna in Peenasa Vyadhi w.r.t Chronic Simple Rhinitis

时间窗: The drug will be given 15 days. The patients will | be assessed before and after treatment. Total | duration of the study will 18 months.

次要结局

  • A comparison between efficacy(of Katphaladi Churna and Tab Levocetrizine 5mg in combination with Montelukast 10mg in Peenasa Vyadhi w.r.t Chronic Simple Rhinitis)

研究者

申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验